<DOC>
	<DOCNO>NCT01481350</DOCNO>
	<brief_summary>Pulmonary hypertension increase perioperative risk patient undergoing cardiac surgery valvular heart disease , especially patient long life mitral valve disease . The present study want test hypothesis intravenous administration sildenafil reduces pulmonary vascular resistance afterload right ventricle .</brief_summary>
	<brief_title>Sildenafil Post-capillary Pulmonary Hypertension Patients Undergoing Cardiac Surgery</brief_title>
	<detailed_description>Pulmonary hypertension represent increase risk perioperative patient undergoing cardiac surgery valvular heart disease especially patient long life mitral valve disease complicate sever pulmonary hypertension , high risk develop post operative right ventricular failure separation cardiopulmonary pas . A recent study show single oral administration sildenafil begin cardiac intervention patient undergo valvular heart surgery complicate pulmonary hypertension reduces pulmonary vascular resistance without induce significant effect systemic vascular resistance . The present study want test hypothesis intravenous administration sildenafil reduces pulmonary vascular resistance afterload right ventricle avoid right ventricular failure . This support wean cardiopulmonary pas patient undergoing cardiac surgery valvular heart disease associate pulmonary hypertension .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>patient undergo valvular heart surgery associate post capillary pulmonary hypertension mean pulmonary arterial pressure ( mPAP ) &gt; 30mmHg pulmonary vascular resistance ( PVR ) &gt; 3Wu . patient young 18 year old ischemic cardiomyopathy Ejection Fraction ( EF ) &lt; 30 % severe Chronic obstructive pulmonary disease ( COPD ) oxygen bronchodilator therapy chronic pulmonary disease , chronic renal failure dialysis hepatic failure patient orotracheal intubation already admit ICU intervention</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>